CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell ...

Access to primary care in Canada is slowly improving, but nearly 6 million Canadians still lack regular access to a primary care professional, according to a new survey. The OurCare Survey 2025 shows ...

Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.

BioInvent International (STO:BINV)46% objective response rate (6 of 13 evaluable patients) and a 92% disease control rate (12 of 13) in relapsed/refractory CTCLImmune activation confirmed by CD8+ T ...

Get affordable, fun and educational Christmas gifts for grandkids at Marshalls ranging from STEM kits and wooden toys to mini ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

Tens of millions of AT&T customers have just over a week to claim their share of a $177 million settlement stemming from two ...